Thornberry grew up in South Bend, Indiana and did a BSc in Natural Sciences at Muhlenberg College in Allentown, Pennsylvania, She joined Merck Research Laboratories as a biochemist in 1979 and became the director of enzymology in 1990
Im going to break down what the research really says
For many of my patients here in Colorado, it feelszepboundweight-loss miracle
Future therapies in the GLP-1 pipeline include more effective new drugs like dual-action agonists, oral pill versions for weight loss, and combination therapies designed to preserve muscle mass during weight loss
Reference: Willard FS et al
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial